"10.1371_journal.pone.0035577","plos one","2012-04-16T00:00:00Z","Gesine Paul; Ilknur Özen; Nicolaj S Christophersen; Thomas Reinbothe; Johan Bengzon; Edward Visse; Katarina Jansson; Karin Dannaeus; Catarina Henriques-Oliveira; Laurent Roybon; Sergey V Anisimov; Erik Renström; Mikael Svensson; Anders Haegerstrand; Patrik Brundin","Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden; Department of Neurology, Scania University Hospital, Lund, Sweden; Lund University Diabetes Centre, Scania University Hospital, Malmö, Sweden; Department of Neurosurgery, Scania University Hospital and Lund Stem Cell Center, Lund University, Lund, Sweden; The Rausing Laboratory, Department of Clinical Medicine, Lund University, Lund, Sweden; NeuroNova AB, Stockholm, Sweden; Department of Neurosurgery, Karolinska Hospital, Stockholm, Sweden; Translational Neurology Group, Department of Clinical Sciences, Wallenberg Neuroscience Center, Lund University, Lund, Sweden; Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America","Conceived and designed the experiments: GP IÖ AH PB KJ KD. Performed the experiments: GP IÖ TR SA NSC LR CHO KJ KD. Analyzed the data: GP IÖ TR NSC EV AH PB ER. Contributed reagents/materials/analysis tools: JB MS. Wrote the paper: GP IÖ EV PB JB.","The following co-authors are full-time employees of NeuroNova AB: K.D., K.J. and A.H. NeuroNova AB is a small Swedish biopharmaceutical company pursuing clinical trials in Parkinson's disease and Amyotrophic Lateral Sclerosis (www.neuronova.com). The company has a general interest in understanding the regenerative capacity of the adult brain but is not pursuing strategies related to commercialization of cultured stem cells or therapies based on stem cell/progenitor transplantation. The company has not sponsored the work performed at the academic institutions. The company employees being co-authors on the manuscript have not been influenced by commercial interest interpreting the data. The authors being employees at NeuroNova AB does also not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.","2012","04","Gesine Paul","GP",15,TRUE,6,9,8,5,TRUE,TRUE,FALSE,0,NA,FALSE
